Press release
Dengue Treatment Market Intelligence Report Covers Trends, Segments And Regional Growth
Dengue Treatment Market
Projected Growth Trajectory of the Dengue Treatment Market
The dengue treatment market is anticipated to grow swiftly, reaching a valuation of $4 billion by 2030. This expansion corresponds to a compound annual growth rate (CAGR) of 11.2%. Key contributors to this growth include the broader availability of dengue vaccines, increased mosquito proliferation due to climate changes, strengthened public health infrastructure, better access to diagnostic tools, and more active government involvement. Important developments expected over the forecast period involve a stronger emphasis on supportive care management, wider implementation of dengue vaccination programs, enhanced surveillance for severe dengue cases, hospital-centered treatment protocols, and improved public health monitoring systems.
The dengue treatment market size has grown rapidly in recent years. It will grow from $2.34 billion in 2025 to $2.61 billion in 2026 at a compound annual growth rate (CAGR) of 11.5%. The growth in the historic period can be attributed to high dengue prevalence in tropical regions, lack of antiviral treatments, dependence on supportive care, hospital-centered management, seasonal outbreak patterns.
Download a free sample of the dengue treatment market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20745&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Leading Organizations Driving the Dengue Treatment Market
Several prominent companies are central to the dengue treatment market, including Sanofi S.A., Bharat Biotech International Limited, Pfizer Inc., Merck & Co Inc., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Panacea Biotec Ltd, Serum Institute of India Pvt Ltd, InBios International Inc, GeneOne Life Science Inc, VLP Therapeutics Inc, AstraZeneca plc, Bayer AG, Eli Lilly and Company, VBI Vaccines Inc, Emergex Vaccines Holding Limited, Butantan Institute, Medigen Vaccine Biologics Corporation, and Immunoforge.
In a notable development in February 2024, Takeda Pharmaceutical Company, headquartered in Japan, formed a partnership with India-based Biological E. Limited. This collaboration aims to ramp up the production of Takeda's dengue vaccine, TAK-003, targeting an output of 50 million doses annually. This initiative is intended to secure sustainable access to vaccines in dengue-endemic areas and strengthen global efforts to prevent the disease.
View the full dengue treatment market report:
https://www.thebusinessresearchcompany.com/report/dengue-treatment-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Important Trends Shaping the Future of the Dengue Treatment Market
Companies in the dengue treatment space are increasingly focusing on developing broad-spectrum antiviral medications that can tackle multiple dengue virus serotypes and improve overall treatment outcomes. Such drugs are designed to be effective against a wide array of viruses rather than just a single pathogen. For example, in September 2024, Hyundai Pharmaceutical Co. Ltd., a South Korean pharmaceutical firm, introduced XAFTY-an innovative broad-spectrum antiviral that addresses several viral infections, including COVID-19 and dengue fever. XAFTY is notable for its enhanced absorption and efficacy of niclosamide, a proven safety profile backed by clinical trials, the ability to combat various RNA viruses, adaptability for future viral threats, and a rapid deployment capability to aid regions facing urgent public health emergencies.
Detailed Market Segmentation of the Dengue Treatment Industry
This report categorizes the dengue treatment market into several key segments:
1) By Type: Vaccines and Acetaminophen
2) By Route of Administration: Parenteral and Oral
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
4) By End User: Hospitals, Specialty Clinics, and Home Healthcare
Further subcategorization includes:
- Vaccines: Live Attenuated Vaccines, Recombinant Vaccines, and Inactivated Vaccines
- Acetaminophen: Oral Acetaminophen and Intravenous Acetaminophen
Together, these classifications provide a granular perspective on the market's structure and areas of focus.
What's new in our 2026 market reports:
• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel dashboards
• Market hotspots infographics
• Key technologies and future trends
• Updated graphics and tables
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Dengue Treatment Market Intelligence Report Covers Trends, Segments And Regional Growth here
News-ID: 4605519 • Views: …
More Releases from The Business Research Company
CRISPR Technology Market Outlook Highlights Strategic Opportunities Across The I …
The evolving landscape of gene editing is rapidly transforming biotechnology and medicine, with CRISPR technology at the forefront of this revolution. This market is witnessing remarkable expansion driven by breakthroughs in gene editing therapies and innovative agricultural applications. Let's explore the current market size, key players, notable trends, and the segmentation shaping the future of the CRISPR technology industry.
Projected Market Size of the CRISPR Technology Industry by 2030
The…
Craniomaxillofacial (CMF) Distraction System Market Study Explores Industry Grow …
The craniomaxillofacial (CMF) distraction system market is on track for notable expansion in the coming years. Driven by technological advancements and evolving surgical practices, this segment is poised to experience significant growth as more patients benefit from improved reconstructive procedures. Let's explore the market's projected size, key contributors, emerging trends, and segmentation to understand its future trajectory.
Projected Market Size and Growth for the Craniomaxillofacial Distraction System Market
The market…
COVID-19 Saliva Screening Test Potential Market Research Reveals Path To $6.46 B …
The COVID-19 saliva screening test market is positioned for significant expansion in the coming years. Growing emphasis on public health readiness, the rise of decentralized testing, and increased demand for large-scale, cost-effective screening methods are key factors driving this upward trend. Advancements in saliva-based diagnostic technology also contribute to the promising outlook for this sector.
Projected Market Value and Growth Trajectory of the COVID-19 Saliva Screening Test Potential Market
The…
Dental Caries Treatment Market Research Reveals Strong 5.3% CAGR Outlook Through …
The dental caries treatment market is set for notable expansion as global awareness of oral health continues to rise. Driven by technological advancements and increased access to dental care, this sector is evolving rapidly to meet the demands of both patients and practitioners. Below, we delve into the market's forecast, key players, influential trends, and comprehensive segmentation.
Forecasted Market Size and Growth Trajectory of the Dental Caries Treatment Market
The…
More Releases for Dengue
Dengue Rapid Test Market To Witness Substantial Growth, 2026-2033| SD Biosensor …
The qualitative latest Research report (2026-2033) on the Dengue Rapid Test Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
➤ Request a Sample Copy (Complete TOC,…
Key Trend Reshaping the Dengue Treatment Market in 2025: Innovative Drug Deliver …
Which drivers are expected to have the greatest impact on the over the dengue treatment market's growth?
The escalation in cases of dengue is projected to stimulate the expansion of the market for dengue treatments. Dengue is a viral infection transmitted by mosquito bites, causing symptoms akin to the flu and can escalate to intense complications if not treated. The escalation is primarily due to progressing urbanization, climate alterations favourable to…
Key Dengue Vaccine Market Trend for 2025-2034: Advancements In Dengue Tetravalen …
What Is the Future Outlook for the Dengue Vaccine Market's Size and Growth Rate?
In the past few years, the dengue vaccine market has experienced significant growth. From $0.64 billion in 2024, it is projected to reach $0.72 billion in 2025, marking a compound annual growth rate (CAGR) of 12.4%. This notable expansion during the historical period can be credited to factors such as an increase in travel and urbanization trends,…
Dengue Vaccine Market : An Detailed Overview
Introduction:
Dengue fever is a mosquito-borne viral infection caused by the dengue virus, transmitted primarily through Aedes aegypti and Aedes albopictus mosquitoes. Affecting millions globally each year, dengue has become a significant public health concern, especially in tropical and subtropical regions. The development of dengue vaccines represents a groundbreaking advancement in preventing the disease, reducing its associated healthcare costs, and controlling outbreaks. With increasing awareness and investments in immunization programs, the…
Dengue Vaccine Market : An Overview
Introduction:
Dengue fever is a mosquito-borne viral infection that has become a significant public health challenge in tropical and subtropical regions. The disease is caused by the dengue virus, which is transmitted primarily by Aedes aegypti mosquitoes. With approximately 390 million infections annually, dengue fever places a substantial burden on healthcare systems and economies worldwide. Efforts to mitigate this burden have led to the development of dengue vaccines, designed to prevent…
"Rising Incidence of Dengue Fever Propels Dengue Virus Diagnostic Tests Market T …
According to WHO, dengue affects about 50-100 million people worldwide, annually. It is a vector-borne highly communicable disease. This report discusses the diagnostic tests used to confirm the presence of dengue in one individual.
It is true that the growth of the global dengue virus diagnostic tests market is primarily driven by an increase in the incidence of dengue fever, which is a mosquito-borne viral infection that can cause severe flu-like…
